High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia

Hepatology

Volumn 23, Issue 6, 1996, Pages 1377-1383

  Ferro, Domenico ^a,c   Quintarelli, Claudio ^a   Lattuada, Antonella ^b   Leo, Roberto ^a   Alessandroni, Maria ^a   Mannucci, Pier Mannuccio ^b   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; COLISTIN; ENDOTOXIN; NEOMYCIN; NYSTATIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; ENDOTOXEMIA; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MEDICAL RECORD; PRIORITY JOURNAL;

EID: 0029939485     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008675154     Document Type: Article

References (12)

1. Adams DH, Burra P, Hubscher SG, Elias E, Newman W. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. HEPATOLOGY 1994;19:588-594.
2. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. HEPATOLOGY 1993;18:1139-1143.
3. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide. Lancet 1991;337:776-778.
4. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. HEPATOLOGY 1994;20:1343-1350.
5. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
6. Ferro D, Quintarelli C, Saliola M, Alessandri C, Basili S, Bonavita MS, Violi F. Prevalence of hyperfibrinolysis in patients with liver cirrhosis. Fibrinolysis 1993;7:59-62.
7. Hersch SL, Kunelis T, Francis RB. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for plasminogen activator inhibitor. Blood 1987;69:1315-1319.
8. Violi F, Ferro D, Basili S, Quintarelli C, Musca A, Cordova C, Balsano F, et al. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. HEPATOLOGY 1993;17:78-83.
9. Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin and histamine. J Lab Clin Med 1987;109:97-104.
10. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983;71: 1893-1896.
11. Ruggeri ZM, Ware J. The structure and function of von Willebrand factor. Thromb Haemost 1992;67:594-599.
12. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral blood in patients with cirrhosis. HEPATOLOGY 1988;8:232-236.